Summary
- Main use
- Correction of nutritional deficiencies through intravenous nutrition (water, electrolytes, amino acids, etc.)
- Who uses it
- Adults · Children
- Adult dosage
- The dose and bag size should be determined according to the patient's condition, energy expenditure, metabolic capacity, body weight, and additional calories or protein supplied orally or via the gastrointestinal tract. Trace elements, vitamins, electrolytes, etc. may be added depending on the patient's condition. The maximum daily doses specified below must not be exceeded. Because the composition of the multi-chamber bag is fixed, it may not be possible to meet all of the patient's nutritional requirements simultaneously. Clinical situations may arise in which the patient requires amounts of nutrients different from the fixed composition of this drug. In all dose (volume administered) adjustments, the effect on the administration of all other nutrients in this drug must be taken into account. 1. Adults Recommended daily amount - 0.16 g-0.35 g of nitrogen per kg of body weight (equivalent to 1 g-2 g of amino acids per kg of body weight), depending on the patient's nutritional status and degree of catabolism - 20-40 kcal of total energy per kg of body weight - 20-40 mL of total volume per kg of body weight, or 1-1.5 mL per kcal expended Maximum daily dose - The maximum daily dose is 26 mL per kg of body weight (equivalent to 2.0 g of amino acids, 1.9 g of glucose, and 0.9 g of fat per kg of body weight) - In special situations, such as continuous renal replacement therapy, up to 0.4g of nitrogen per kg of body weight (equivalent to 2.5g of amino acids per kg of body weight) may be required. Infusion rate - The infusion rate should not exceed 1.3 mL/kg per hour (equivalent to 0.10 g/kg per hour of amino acids, 0.10 g/kg per hour of glucose, and 0.05 g/kg per hour of fat). 3. Method and duration of administration - Because of its high osmolarity, this drug should be infused only through a central vein. The recommended administration period is 12-24 hours. - In general, gradually increase the infusion rate during the first hour after starting administration, and adjust it taking into account the total volume, daily dose, and infusion time.
- Children's dosage
- 2. Children 2 years and older - The daily requirements for dose, nitrogen, and energy decrease with increasing age. - For patients aged 2 years to 11 years, the limiting factors for the daily dose are the concentrations of amino acids and magnesium, and the limiting factor for the hourly rate is the amino acid concentration. - For patients aged 12 years to 18 years, the limiting factors for the daily dose are the concentrations of amino acids and magnesium, and the limiting factor for the hourly rate is the amino acid concentration. - In general, start young children on a low dose and gradually increase to the maximum dose. 1) Children aged 2 years to 11 years Maximum daily dose - The maximum daily dose is 33 mL per kg of body weight (equivalent to 2.5 g of amino acids, 2.4 g of glucose, 1.2 g of fat, and total energy of 31.4 kcal per kg of body weight) Infusion rate - The infusion rate should not exceed 2.6 mL/kg per hour (equivalent to 0.20 g/kg per hour of amino acids, 0.19 g/kg per hour of glucose, and 0.09 g/kg per hour of fat). 2) Children aged 12 years to 18 years Maximum daily dose - The maximum daily dose is 26 mL per kg of body weight (equivalent to 2 g of amino acids, 1.9 g of glucose, 0.9 g of fat, and total energy of 24.7 kcal per kg of body weight) Infusion rate - The infusion rate should not exceed 1.6 mL/kg per hour (equivalent to 0.12 g/kg per hour of amino acids, 0.12 g/kg per hour of glucose, and 0.06 g/kg per hour of fat)
Ingredients
- L-Alanine2.06g / 100mL
- L-Arginine1.395g / 100mL
- L-Aspartic Acid0.412g / 100mL
- L-Glutamic Acid0.711g / 100mL
- Glycine0.987g / 100mL
- L-Histidine0.849g / 100mL
- L-Isoleucine0.711g / 100mL
- L-Leucine0.987g / 100mL
- L-Lysine Acetate1.58g / 100mL
- L-Methionine0.711g / 100mL
- L-Phenylalanine0.987g / 100mL
- L-Proline0.849g / 100mL
- L-Serine0.562g / 100mL
- L-Threonine0.711g / 100mL
- L-Tryptophan0.237g / 100mL
- L-Tyrosine0.037g / 100mL
- L-Valine0.911g / 100mL
- Sodium Acetate Hydrate0.281g / 100mL
- Potassium Chloride0.419g / 100mL
- Magnesium Chloride Hexahydrate0.152g / 100mL
- Sodium Glycerophosphate Hydrate0.689g / 100mL
- Glucose Monohydrate30.25g / 100mL
- Calcium Chloride Hydrate0.194g / 100mL
- Purified Olive Oil14g / 100mL
- Refined Soyabean Oil3.5g / 100mL
- Importer
- .
Efficacy & effects
Correction of nutritional deficiencies through intravenous nutrition (water, electrolytes, amino acids, etc.)
View approved original textHide original text
This medication is used to provide hydration, electrolytes, amino acids, and calories to pediatric and adult patients aged 2 years and older for whom oral or enteral nutritional support is difficult or insufficient. This helps improve nutritional status and maintain body functions.
Dosage and Administration
Adult dosage
The dose and bag size should be determined according to the patient's condition, energy expenditure, metabolic capacity, body weight, and additional calories or protein supplied orally or via the gastrointestinal tract. Trace elements, vitamins, electrolytes, etc. may be added depending on the patient's condition. The maximum daily doses specified below must not be exceeded. Because the composition of the multi-chamber bag is fixed, it may not be possible to meet all of the patient's nutritional requirements simultaneously. Clinical situations may arise in which the patient requires amounts of nutrients different from the fixed composition of this drug. In all dose (volume administered) adjustments, the effect on the administration of all other nutrients in this drug must be taken into account. 1. Adults Recommended daily amount - 0.16 g-0.35 g of nitrogen per kg of body weight (equivalent to 1 g-2 g of amino acids per kg of body weight), depending on the patient's nutritional status and degree of catabolism - 20-40 kcal of total energy per kg of body weight - 20-40 mL of total volume per kg of body weight, or 1-1.5 mL per kcal expended Maximum daily dose - The maximum daily dose is 26 mL per kg of body weight (equivalent to 2.0 g of amino acids, 1.9 g of glucose, and 0.9 g of fat per kg of body weight) - In special situations, such as continuous renal replacement therapy, up to 0.4g of nitrogen per kg of body weight (equivalent to 2.5g of amino acids per kg of body weight) may be required. Infusion rate - The infusion rate should not exceed 1.3 mL/kg per hour (equivalent to 0.10 g/kg per hour of amino acids, 0.10 g/kg per hour of glucose, and 0.05 g/kg per hour of fat). 3. Method and duration of administration - Because of its high osmolarity, this drug should be infused only through a central vein. The recommended administration period is 12-24 hours. - In general, gradually increase the infusion rate during the first hour after starting administration, and adjust it taking into account the total volume, daily dose, and infusion time.
Children's dosage
2. Children 2 years and older - The daily requirements for dose, nitrogen, and energy decrease with increasing age. - For patients aged 2 years to 11 years, the limiting factors for the daily dose are the concentrations of amino acids and magnesium, and the limiting factor for the hourly rate is the amino acid concentration. - For patients aged 12 years to 18 years, the limiting factors for the daily dose are the concentrations of amino acids and magnesium, and the limiting factor for the hourly rate is the amino acid concentration. - In general, start young children on a low dose and gradually increase to the maximum dose. 1) Children aged 2 years to 11 years Maximum daily dose - The maximum daily dose is 33 mL per kg of body weight (equivalent to 2.5 g of amino acids, 2.4 g of glucose, 1.2 g of fat, and total energy of 31.4 kcal per kg of body weight) Infusion rate - The infusion rate should not exceed 2.6 mL/kg per hour (equivalent to 0.20 g/kg per hour of amino acids, 0.19 g/kg per hour of glucose, and 0.09 g/kg per hour of fat). 2) Children aged 12 years to 18 years Maximum daily dose - The maximum daily dose is 26 mL per kg of body weight (equivalent to 2 g of amino acids, 1.9 g of glucose, 0.9 g of fat, and total energy of 24.7 kcal per kg of body weight) Infusion rate - The infusion rate should not exceed 1.6 mL/kg per hour (equivalent to 0.12 g/kg per hour of amino acids, 0.12 g/kg per hour of glucose, and 0.06 g/kg per hour of fat)
Precautions
This medication must be used according to a physician's instructions. If signs of anaphylactic reactions such as fever, chills, rash, or difficulty breathing appear during administration, administration should be stopped immediately. This medication may cause precipitation when administered with intravenous calcium-containing agents like ceftriaxone; therefore, it must not be administered simultaneously using the same infusion device. If the same infusion line must be used for continuous infusion, the infusion line must be thoroughly cleaned before and after administration. Preterm infants and low-birth-weight infants may experience increased levels of free fatty acids in the blood due to slow metabolism of the lipid components of this medication, which could lead to lipid accumulation in the pulmonary vessels in severe cases and pose a risk. This drug should not be administered to premature infants, neonates, or children under 2 years of age, nor to patients allergic to eggs, soybeans, peanuts, corn, or components of this medication. Administration is contraindicated in patients with certain diseases such as severe renal impairment, liver disease, congenital amino acid metabolism disorders, blood coagulation disorders, hypertriglyceridemia, and hyperglycemia. This medication should be administered cautiously in patients with metabolic disorders such as renal failure, diabetes, pancreatitis, decreased liver function, hypothyroidism, sepsis, heart failure, and lung failure, and electrolyte and fluid status must be stable prior to administration. Overdosage or rapid infusion may cause side effects; care should be taken, and if symptoms such as sweating, fever, chills, headache, rash, or difficulty breathing appear during initial administration, infusion should be stopped immediately. Fluid and electrolyte balance, blood glucose, liver and kidney function, and blood coagulation status must be regularly monitored throughout the administration period. This medication should be infused through a central vein, not a peripheral vein, and if extravasation occurs, infusion should be stopped immediately, and appropriate treatment should be provided. Safety during pregnancy and lactation has not been established; therefore, it should only be given if the benefits of therapy exceed the risks. In pediatric cases, administration should not be done for those under 2 years of age, while for those 2 years and older, pediatric formulations should be used, and vitamins and trace elements must be supplemented. This medication contains corn-derived glucose and may trigger allergic reactions in patients with corn allergies, so caution is required. Symptoms such as acidosis, excessive circulating blood volume, and hyperglycemia may occur in case of overdose, and blood dialysis may be required if necessary. This medication contains vitamin K but does not significantly affect the effect of anticoagulants in the coumarin class. Aseptic procedures must be strictly followed during administration to prevent infections and sepsis, with special attention required for catheter management. Care must be taken to avoid interactions when co-administered with other medications, especially regarding precipitation, and it should not be administered with ceftriaxone, ampicillin, or fosphenytoin.
Side effects
fever, chills, rash, dyspnea, sweating, headache, skin rash, itching, flushing, tachycardia, anorexia, hypertriglyceridemia, abdominal pain, diarrhea, nausea, vomiting, hypertension, pain, irritation, swelling, edema, erythema, warmth, skin necrosis, vesicles, blisters, inflammation, sclerosis, skin tightness, lipodystrophy, hyperlipidemia, fever, hepatic steatosis, hepatomegaly, splenomegaly, impaired liver function, anemia, leukopenia, thrombocytopenia, coagulopathy, coma, thrombocytopenia, cholestasis, hepatomegaly, jaundice, hypersensitivity reaction, liver disease related to intravenous nutrition, increased serum alkaline phosphatase, increased transaminases, increased serum bilirubin, elevated liver enzymes, azotemia, pulmonary embolism, skin rash, extravasation, vomiting, nausea, warmth, sweating, electrolyte disturbance, hyperglycemia, glucosuria, hyperosmolar syndrome, pulmonary deposits, dyspnea
Not everyone experiences these, and they can vary from person to person.
Storage
This medication should be stored in a sealed container and kept at room temperature. Also, care must be taken to prevent freezing.
Appearance and packaging
Appearance
A transparent plastic bag containing a solution, separated into three compartments by two membranes, where the amino acid solution and sugar solution are transparent, colorless to pale yellow liquids, and the fat solution is a homogeneous milky white.
Package unit
650 mL/bag [Amino Acid Solution 347 mL, Sugar Solution 173 mL, Fat Solution 130 mL], 1000 mL/bag [Amino Acid Solution 533 mL, Sugar Solution 267 mL, Fat Solution 200 mL], 1500 mL/bag [Amino Acid Solution 800 mL, Sugar Solution 400 mL, Fat Solution 300 mL], 2000 mL/bag [Amino Acid Solution 1,067 mL, Sugar Solution 533 mL, Fat Solution 400 mL]
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.